BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. Jul 24, 2026; 17(7): 122710
Published online Jul 24, 2026. doi: 10.5306/wjco.122710
Figure 1
Figure 1 Random forest analysis and survival curves. A: Lymphovascular invasion status; B: Perineural invasion status; C: Kaplan-Meier curves illustrate recurrence-free survival. pTNM: Pathological tumor-node-metastasis; LVI: Lymphovascular invasion; PNI: Perineural invasion; BMI: Body mass index; CEA: Carcinoembryonic antigen; CA19-9: Cancer antigen 19-9.
Figure 2
Figure 2 Prognostic nomogram construction and calibration. A: Multivariable predictive model integrating tumor-node-metastasis stage, lymphovascular invasion, perineural invasion, and body mass index for recurrence-free survival estimation; B: Calibration plots demonstrate agreement between predicted and observed outcomes for 1-year, 3-year, and 5-year recurrence-free survival; C: Time-dependent receiver operating characteristic analysis of the nomogram’s predictive accuracy. pTNM: Pathological tumor-node-metastasis; LVI: Lymphovascular invasion; PNI: Perineural invasion; BMI: Body mass index; RFS: Recurrence-free survival.
Figure 3
Figure 3 Decision curve analysis evaluating clinical utility of the nomogram across threshold probabilities. RFS: Recurrence-free survival.


Write to the Help Desk